Centro de Imagem Diagnosticos SA
BOVESPA:AALR3
Relative Value
The Relative Value of one
AALR3
stock under the Base Case scenario is
12.23
BRL.
Compared to the current market price of 4.8 BRL,
Centro de Imagem Diagnosticos SA
is
Undervalued by 61%.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Multiples Across Competitors
AALR3 Competitors Multiples
Centro de Imagem Diagnosticos SA Competitors
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| BR |
|
Centro de Imagem Diagnosticos SA
BOVESPA:AALR3
|
731.1m BRL | 0.6 | -8.4 | 4.8 | 8.5 | |
| US |
|
CVS Health Corp
NYSE:CVS
|
97.3B USD | 0.2 | 55.8 | 14.1 | 14.1 | |
| US |
C
|
Cigna Group
XMUN:CGN
|
69.1B EUR | 0.3 | 13.5 | 7.9 | 10 | |
| US |
|
Cigna Corp
NYSE:CI
|
70.1B USD | 0.3 | 11.9 | 0 | 0 | |
| DE |
|
Fresenius SE & Co KGaA
XETRA:FRE
|
26.3B EUR | 1.2 | 21 | 9.8 | 14.6 | |
| DE |
|
Fresenius Medical Care AG
XMUN:FME
|
23B EUR | 1.2 | 23.5 | 9 | 16.7 | |
| US |
|
Laboratory Corporation of America Holdings
NYSE:LH
|
21.8B USD | 1.6 | 25 | 12.1 | 17.5 | |
| US |
|
Quest Diagnostics Inc
NYSE:DGX
|
21.7B USD | 2 | 22 | 12.2 | 16.6 | |
| DE |
F
|
Fresenius Medical Care AG & Co KGaA
XETRA:FME
|
11.1B EUR | 0.6 | 11.4 | 5.4 | 10 | |
| US |
|
Guardant Health Inc
NASDAQ:GH
|
11.9B USD | 12 | -28.2 | -30.3 | -27.6 | |
| US |
|
DaVita Inc
NYSE:DVA
|
10.3B USD | 0.8 | 13.9 | 7.3 | 9.9 |